https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/
Weight loss drugs on the horizon: STAT's Obesity Drug Tracker
Jun 17, 2025 - Our database tracks the new weight loss drugs that could hit the market, novel mechanisms, and which companies are in the hunt.
weight loss drugson the horizonstatobesitytracker
https://www.statnews.com/2024/09/05/obesity-drug-tracker-amylin-weight-loss-drugs-novo-nordisk-eli-lilly-zealand-pharma/
Obesity drug tracker: Can amylin drugs upend Wegovy, Zepbound? | STAT
Sep 5, 2024 - Novo Nordisk and Eli Lilly, makers of blockbuster GLP-1 drugs, test amylin hormone receptor treatments in pursuit of fewer side effects.
obesity drug trackerdrugswegovyzepboundstat